Cryoport, Inc. a provider of life sciences supply chain solutions, and Medipal Holdings Corp., a pharma wholesaler and distributor based in Japan, entered a multi-year strategic alliance to create an integrated regenerative medicine supply chain solution in Japan. The companies will partner to provide integrated, end-to-end distribution solutions for specialty cell and gene therapies that demand stringent temperature control, track and trace systems and global distribution. To meet demand fr...